search
Back to results

A Trial of Percutaneous Lumbar Discectomy Combined With Ozone for Treatment of LDH

Primary Purpose

Lumbar Disc Herniation

Status
Unknown status
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
percutaneous lumbar discectomy
ozone therapy
Sponsored by
Zhongda Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lumbar Disc Herniation focused on measuring Herniation, Discectomy, Ozone

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age older than 18 years.
  • 4 or more weeks low back pain and/or lower-limb radiation pain.
  • MRI and/or CT test confirm diagnosis lumbar disc herniation and level(s).
  • Invalid after Non-steroidal anti-inflammatory medical therapy and physical therapy.
  • Pain level(Visual Analog Scale)≥5.

Exclusion Criteria:

  • Spinal tumors.
  • Spine infections, fractures, slippage(more than I °) and other deformities.
  • Combining with spinal stenosis, lateral recess stenosis, yellow ligament hypertrophy.
  • Nucleus pulposus herniated too much, dural sac compressed more than 50%;
  • Psychological, cognitive disorders which may affect the reliability of the outcome;
  • Previous lumbar disc surgery;
  • Bleeding tendency or severe cardiovascular disease can not tolerate surgery;
  • Don't accept the trial's informed consent;
  • Possible pregnancy.

Sites / Locations

  • Zhongda Hospital,Southeast University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

PLD combined with ozone

pure PLD

Arm Description

Patients diagnosed as lumbar disc herniation undergoing percutaneous lumbar discectomy combined with ozone therapy.

Patients diagnosed as lumbar disc herniation undergoing percutaneous lumbar discectomy(PLD).

Outcomes

Primary Outcome Measures

Changes from baseline in Visual Analog Scale(VAS)
Changes from baseline in Oswestry Low Back Disability Questionnaire(ODI)
Changes from baseline in Japanese Orthopaedic Association Scores(JOA)

Secondary Outcome Measures

Response evaluation measured by MacNab criteria
Response evaluation as measured by MacNab criteria

Full Information

First Posted
February 6, 2015
Last Updated
July 12, 2016
Sponsor
Zhongda Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02372032
Brief Title
A Trial of Percutaneous Lumbar Discectomy Combined With Ozone for Treatment of LDH
Official Title
Percutaneous Lumbar Discectomy (PLD) Combined With Ozone Versus Percutaneous Lumbar Discectomy (PLD) for Treatment of Lumbar Disc Herniation:A Single-Blind Prospective Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
February 2015 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
September 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zhongda Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Lumbar disc herniation (LDH) is a common pathological process leading to spinal surgery. Open discectomy used to be a widespread procedure for surgical treatment for symptomatic LDH. Currently, several minimal invasive surgeries have been uesd widely. Percutaneous lumbar discectomy(PLD) and ozone therapy are two widely used minimal invasive treatment, and ozone therapy combined other minimally invasive treatment could improve other minimally invasive treatment's clinical effectiveness. The effectiveness of which has been proved to be comparable to conventional open discectomy. In this study, a single-blind randomized controlled trial will be performed to evaluate the effectiveness of two minimal invasive discectomy, percutaneous lumbar discectomy combined with ozone and percutaneous lumbar discectomy, for the treatment of symptomatic LDH. Two groups of patients will be investigated; 1) patients diagnosed with lumbar disc herniation undergoing PLD combined with ozone, and 2) patients diagnosed with lumbar disc herniation undergoing PLD. The primary endpoints of the study will be changes in in pain and functional status by the Visual Analog Scale (VAS) and functional status as measured by Oswestry Low Back Disability Questionnaire (Oswestry Disability Index,ODI) and Japanese Orthopaedic Association (JOA) as measured at pre- and post-operation, 1 month, 3 months, 6 months. Secondary outcomes include response evaluation by MacNab response evaluation criteria as measured at pre- and post-operation, 1 month, 3 months, 6 months. Treatment effect is defined as the difference in the mean change from baseline between the two groups. For the first time,the results of this trial will provide scientific evidence as to the relative effectiveness of PLD combined with ozone versus PLD for minimal invasive surgical treatment for symptomatic lumbar disc herniation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Disc Herniation
Keywords
Herniation, Discectomy, Ozone

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PLD combined with ozone
Arm Type
Experimental
Arm Description
Patients diagnosed as lumbar disc herniation undergoing percutaneous lumbar discectomy combined with ozone therapy.
Arm Title
pure PLD
Arm Type
Active Comparator
Arm Description
Patients diagnosed as lumbar disc herniation undergoing percutaneous lumbar discectomy(PLD).
Intervention Type
Procedure
Intervention Name(s)
percutaneous lumbar discectomy
Intervention Description
process percutaneous lumbar discectomy
Intervention Type
Procedure
Intervention Name(s)
ozone therapy
Intervention Description
percutaneous intradiscal ozone injection
Primary Outcome Measure Information:
Title
Changes from baseline in Visual Analog Scale(VAS)
Time Frame
Baseline, post-op 1 month, 3 months, 6 months
Title
Changes from baseline in Oswestry Low Back Disability Questionnaire(ODI)
Time Frame
Baseline, post-op 1 month, 3 months, 6 months
Title
Changes from baseline in Japanese Orthopaedic Association Scores(JOA)
Time Frame
Baseline, post-op 1 month, 3 months, 6 months
Secondary Outcome Measure Information:
Title
Response evaluation measured by MacNab criteria
Description
Response evaluation as measured by MacNab criteria
Time Frame
post-op 1 month, 3 months, 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age older than 18 years. 4 or more weeks low back pain and/or lower-limb radiation pain. MRI and/or CT test confirm diagnosis lumbar disc herniation and level(s). Invalid after Non-steroidal anti-inflammatory medical therapy and physical therapy. Pain level(Visual Analog Scale)≥5. Exclusion Criteria: Spinal tumors. Spine infections, fractures, slippage(more than I °) and other deformities. Combining with spinal stenosis, lateral recess stenosis, yellow ligament hypertrophy. Nucleus pulposus herniated too much, dural sac compressed more than 50%; Psychological, cognitive disorders which may affect the reliability of the outcome; Previous lumbar disc surgery; Bleeding tendency or severe cardiovascular disease can not tolerate surgery; Don't accept the trial's informed consent; Possible pregnancy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gao-jun Teng, Ph.D,MD
Organizational Affiliation
Zhongda Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zhongda Hospital,Southeast University
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210009
Country
China

12. IPD Sharing Statement

Learn more about this trial

A Trial of Percutaneous Lumbar Discectomy Combined With Ozone for Treatment of LDH

We'll reach out to this number within 24 hrs